| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $7,258,752 ) |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01AA029605 | Attending to all children: Examining the role of alpha oscillations in attention in young children with and without prenatal alcohol exposure (AsCENd) Administrative Supplement | 001 | 3 | NIH | 9/6/2024 | $115,854 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01AA029605 | Attending to all children: Examining the role of alpha oscillations in attention in young children with and without prenatal alcohol exposure (AsCENd) Administrative Supplement | 000 | 3 | NIH | 7/19/2024 | $761,552 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA058004 | Matching Treatments to Cognitive Deficits in Offenders with Substance Use Disorders | 000 | 1 | NIH | 9/16/2024 | $812,460 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL163512 | Mechanism and Countermeasure of Fentanyl-Induced Sudden Death | 001 | 2 | NIH | 6/12/2024 | $73,272 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL163512 | Mechanism and Countermeasure of Fentanyl-Induced Sudden Death | 000 | 2 | NIH | 11/13/2023 | $824,319 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R21AG089266 | The mechanisms of cerebral microcirculation response to transcranial stimulation. | 000 | 1 | NIH | 9/10/2024 | $596,750 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA055158 | Neurocognitive Abnormalities in Stimulant Abuse among High-Risk Women | 001 | 3 | NIH | 5/15/2024 | $802,751 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS126742 | A longitudinal study of traumatic brain injury in a high-risk population | 001 | 3 | NIH | 9/17/2024 | $180,788 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS133569 | Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | 001 | 2 | NIH | 8/1/2024 | $52,099 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS133569 | Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | 001 | 2 | NIH | 8/1/2024 | $838,011 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R61AA030819 | The synchrony study: A randomized controlled trial of music training for children with FASD | 000 | 2 | NIH | 8/3/2024 | $307,308 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA059063 | Mechanism and Countermeasure of Carfentanil-induced Respiratory Disorder and Death | 000 | 2 | NIH | 4/23/2024 | $651,000 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS126742 | A longitudinal study of traumatic brain injury in a high-risk population | 000 | 3 | NIH | 5/30/2024 | $650,044 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS129407 | Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome. | 000 | 2 | NIH | 5/29/2024 | $709,373 |
| | 2024 | 2024 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS133569 | Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | 000 | 1 | NIH | 2/16/2024 | $42,140 |
| | 2024 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 001 | 7 | NIH | 9/26/2024 | -$16,480 |
| | 2024 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA055158 | Neurocognitive Abnormalities in Stimulant Abuse among High-Risk Women | 000 | 2 | NIH | 10/31/2023 | $0 |
| | 2024 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01AA026290 | Mindfulness for Alcohol Abusing Offenders: Mechanisms and Outcomes | 000 | 6 | NIH | 4/5/2024 | $0 |
| | 2024 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 001 | 6 | NIH | 1/10/2024 | $105,902 |
| | 2024 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 002 | 6 | NIH | 2/23/2024 | -$132,034 |
| | 2024 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HD092331 | Externalizing outcomes in high risk youth | 000 | 5 | NIH | 9/11/2024 | $0 |
| | 2024 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | P30GM122734 | Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND) | 000 | 6 | NIH | 3/20/2024 | $0 |
| | 2024 | 2021 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA196590 | Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy | 000 | 7 | NIH | 1/11/2024 | -$116,357 |
|
| Issue Date FY: 2023 ( Subtotal = $6,881,650 ) |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA055158 | Neurocognitive Abnormalities in Stimulant Abuse among High-Risk Women | 001 | 2 | NIH | 5/19/2023 | $808,853 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS133569 | Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | 000 | 1 | NIH | 7/28/2023 | $815,866 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R61AA030819 | The synchrony study: A randomized controlled trial of music training for children with FASD | 000 | 1 | NIH | 8/4/2023 | $311,724 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R61AA030819 | The synchrony study: A randomized controlled trial of music training for children with FASD | 001 | 1 | NIH | 9/26/2023 | $311,724 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS126742 | A longitudinal study of traumatic brain injury in a high-risk population | 001 | 2 | NIH | 5/31/2023 | $689,950 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 002 | 7 | NIH | 7/12/2023 | $442,538 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL163512 | Mechanism and Countermeasure of Fentanyl-Induced Sudden Death | 000 | 1 | NIH | 12/28/2022 | $940,773 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01AA029605 | Attending to all children: Examining the role of alpha oscillations in attention in young children with and without prenatal alcohol exposure (AsCENd) Administrative Supplement | 000 | 2 | NIH | 6/19/2023 | $414,167 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01AA029605 | Attending to all children: Examining the role of alpha oscillations in attention in young children with and without prenatal alcohol exposure (AsCENd) Administrative Supplement | 000 | 2 | NIH | 6/19/2023 | $320,000 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA059063 | Mechanism and Countermeasure of Carfentanil-induced Respiratory Disorder and Death | 000 | 1 | NIH | 5/23/2023 | $651,000 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R61AA030819 | The synchrony study: A randomized controlled trial of music training for children with FASD | 001 | 1 | NIH | 9/26/2023 | -$311,724 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS129407 | Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome. | 000 | 1 | NIH | 6/26/2023 | $737,345 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS126742 | A longitudinal study of traumatic brain injury in a high-risk population | 002 | 2 | NIH | 9/11/2023 | $269,847 |
| | 2023 | 2023 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R03AG075408 | Cerebrovascular contributions to cognitive impairment in Lewy body dementias | 000 | 2 | NIH | 2/1/2023 | $181,000 |
| | 2023 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HD092331 | Externalizing outcomes in high risk youth | 000 | 5 | NIH | 4/6/2023 | $0 |
| | 2023 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DA055158 | Neurocognitive Abnormalities in Stimulant Abuse among High-Risk Women | 000 | 1 | NIH | 2/7/2023 | $0 |
| | 2023 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01AA026290 | Mindfulness for Alcohol Abusing Offenders: Mechanisms and Outcomes | 002 | 6 | NIH | 6/9/2023 | $702,883 |
| | 2023 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | P30GM122734 | Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND) | 000 | 6 | NIH | 8/10/2023 | $0 |
| | 2023 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES031787 | Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats | 001 | 3 | NIH | 5/31/2023 | $83,997 |
| | 2023 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS126742 | A longitudinal study of traumatic brain injury in a high-risk population | 000 | 1 | NIH | 3/3/2023 | $0 |
| | 2023 | 2021 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 001 | 5 | NIH | 5/15/2023 | -$197,036 |
| | 2023 | 2021 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 000 | 5 | NIH | 5/15/2023 | -$291,258 |
|
| Issue Date FY: 2022 ( Subtotal = $7,426,676 ) (Continued on the next page) |
| | 2022 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 003 | 6 | NIH | 9/10/2022 | $442,538 |
| | 2022 | 2022 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS126742 | A longitudinal study of traumatic brain injury in a high-risk population | 000 | 1 | NIH | 8/3/2022 | $689,950 |
|
